Related Experiment Video

Updated: Aug 13, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Characterizing the protective component of the alphabeta T cell response to transplantable squamous cell carcinoma

Michael Girardi1, David Oppenheim, Earl J Glusac

  • 1Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06520-8059, USA. girardi@yale.edu

The Journal of Investigative Dermatology
|April 17, 2004
PubMed

Insights

Cellular immune responses show promise in fighting cancer. This study identifies specific T cell activities, including CD8(+) and interferon-gamma (IFNγ)-producing CD4(+) cells, that inhibit squamous cell carcinoma (SCC) growth.

Area of Science:

  • Immunology
  • Oncology
  • Cellular Biology

Background:

  • Manipulating cellular immune responses offers potential for cancer treatment.
  • Immune responses to skin cancer involve diverse T cell activities that can either inhibit or promote tumor progression.
  • Understanding these T cell activities is vital for effective clinical cancer therapies.

Purpose of the Study:

  • To investigate the protective anti-tumor effects of alphabeta T cells in cutaneous squamous cell carcinoma (SCC).
  • To characterize the specific T cell components responsible for inhibiting SCC tumor growth.
  • To identify how these T cells impact tumor physiology.

Main Methods:

  • Examined the growth of a transplantable SCC line (PDV) in immunocompetent versus alphabeta T cell-deficient mice.
  • Analyzed the roles of CD8(+) and CD4(+) T cells producing interferon-gamma (IFNγ).
  • Assessed changes in tumor necrosis, stromal bed, and Rae-1 expression.

Main Results:

  • Alphabeta T cell-deficient mice exhibited significantly greater SCC tumor growth compared to immunocompetent mice.
  • The protective anti-tumor response involves CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells producing IFNγ.
  • Tumor growth inhibition was associated with increased focal necrosis, decreased stromal bed, and reduced expression of Rae-1, a ligand for NKG2D.

Conclusions:

  • Specific components of the alphabeta T cell immune response possess protective potential against SCC.
  • CD8(+) and IFNγ-producing CD4(+) T cells are key mediators of anti-tumor immunity in this model.
  • Tumor expression of Rae-1 is modulated by the anti-tumor T cell response, suggesting a mechanism for immune evasion.

More Related Videos

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Radial Mobility and Cytotoxic Function of Retroviral Replicating Vector Transduced, Non-adherent Alloresponsive T Lymphocytes10:01

Radial Mobility and Cytotoxic Function of Retroviral Replicating Vector Transduced, Non-adherent Alloresponsive T Lymphocytes

Published on: February 11, 2015

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...